DIN 02563673 — NEMLUVIO 30 MG
NEMLUVIO is a powder for solution of Nemolizumab marketed by GALDERMA CANADA INC.. The full Nemolizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02563673
- Brand name
- NEMLUVIO
- Active ingredient
- Nemolizumab
- Strength
- 30 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- GALDERMA CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Interleukin-31 receptor alpha (IL-31RA) inhibitor (immunomodulator, monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.